abstract |
The present invention provides antibodies that bind to human GFRα3 and methods of using the same. According to some embodiments of the present invention, the antibody is a fully human antibody that binds to human GFRα3. Antibodies of the invention are useful in the treatment of diseases or disorders associated with one or more biological activities of GFRα3, including the treatment of acute or chronic pain conditions or inflammatory conditions. |